Log In
Print
BCIQ
Print
Print this Print this
 

Epogen, epoetin alfa

Also known as: Epoetin alfa/Epoetin beta, erythropoietin

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionErythropoietin (EPO) receptor agonist
Molecular Target Erythropoietin (EPO) receptor
Mechanism of ActionErythropoietin (EPO) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsMaintain hematocrit in dialysis patients; Red blood cell stimulation in end-stage renal disease (ESRD); Treat anemia; Treat anemia associated with chemotherapy; Treat anemia associated with chronic renal failure (CRF); Treat anemia in dialysis patients; Treat anemia in patients with chronic kidney disease (CKD); Treat anemia in zidovudine-treated HIV-infected patients; Treat chemotherapy-induced anemia (CIA) in patients with cancer; Treat dialysis patients with cardiovascular disease (CVD); Treat patients with cardiac disease on hemodialysis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today